Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Feb 17;31(5):1116–1123. doi: 10.1161/ATVBAHA.110.214601

Figure 4.

Figure 4

Bone marrow reconstitution shows a strong effect of cardiac CyPA for recruitment of bone marrow-derived cells in response to AngII, and development of cardiac hypertrophy. GFP+ bone marrow cells (Ppia+/+) were transplanted into irradiated Apoe−/− or Apoe−/− Ppia−/− mice. After 6 weeks, these chimeric mice with GFP+ bone marrow were infused with saline (AB) or AngII for 4 weeks (CD). (AD) Representative PECAM-1 staining (red) of hearts from Apoe−/− and Apoe−/− Ppia−/− recipient mice with GFP+ bone marrow (green). Statistical analysis of the number of migrating GFP+ bone marrow in the cardiac tissue (E) or perivascular area (F) in the hearts of Apoe−/− (n = 9) and Apoe−/− Ppia−/− (n = 8) mice. (G) AngII-induced cardiac hypertrophy (heart weight per body weight ratio) was significantly less in Apoe−/− Ppia−/− recipient mice (n = 9) compared with Apoe−/− recipient mice (n = 8) with Ppia+/+ bone marrow. (H) Heart weight per body weight ratio after AngII infusion for 4 weeks, was significantly less in ApoE−/− Ppia−/− (n = 6) compared to ApoE−/− (n = 6) chimeric mice with Ppia−/− bone marrow. Results are mean ± SD. # equals P< 0.05 in Saline versus AngII; *equals P< 0.05 in Apoe−/− versus Apoe−/− Ppia−/− mice.